News
31mon MSN
Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval
Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback